Lobe Sciences Ltd. LOBEF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | 182.00K |
| Gross Profit | -- | -- | -- | -- | -182.00K |
| SG&A Expenses | 2.96M | 2.89M | 2.42M | 2.54M | 1.73M |
| Depreciation & Amortization | -- | -- | -- | -- | 0.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.98M | 4.87M | 3.58M | 3.01M | 2.12M |
| Operating Income | -4.98M | -4.87M | -3.58M | -3.01M | -2.12M |
| Income Before Tax | -5.12M | -5.10M | -3.85M | -3.50M | -3.92M |
| Income Tax Expenses | -- | -- | -- | -- | 24.10K |
| Earnings from Continuing Operations | -5.12 | -5.10 | -3.85 | -3.50 | -3.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.37M | 1.03M | 592.80K | 313.70K | 107.00K |
| Net Income | -3.75M | -4.07M | -3.26M | -3.19M | -3.84M |
| EBIT | -4.98M | -4.87M | -3.58M | -3.01M | -2.12M |
| EBITDA | -1.33M | -2.06M | -2.49M | -2.94M | -2.08M |
| EPS Basic | -0.72 | -0.73 | -0.72 | -0.73 | -0.18 |
| Normalized Basic EPS | -0.46 | -0.46 | -0.46 | -0.46 | -0.04 |
| EPS Diluted | -0.72 | -0.73 | -0.72 | -0.73 | -0.18 |
| Normalized Diluted EPS | -0.46 | -0.46 | -0.46 | -0.46 | -0.04 |
| Average Basic Shares Outstanding | 816.41M | 731.43M | 648.31M | 554.81M | 565.05M |
| Average Diluted Shares Outstanding | 816.41M | 731.43M | 648.31M | 554.81M | 565.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |